Crinetics Pharmaceuticals Inc (CRNX)
EBITDA Growth
-14.57%
Quarterly · Period ending:
CRNX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-14.57%period ending
Latest reported-14.57%period ending
CRNX Quarterly EBITDA YoY % (-112.57% → -14.57%)
Year-over-year change
High-resolution chart · PNG
CRNX ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -14.5695% | |
| -32.1714% | |
| -52.419% | |
| -69.7113% | |
| -56.4459% | |
| -44.2293% | |
| -33.3785% | |
| -33.0034% | |
| -44.5827% | |
| -45.3798% | |
| -33.8261% | |
| -37.21% | |
| -20.2538% | |
| -32.934% | |
| -46.3104% | |
| -50.9052% | |
| -63.0002% | |
| -51.5246% | |
| -41.6999% | |
| -51.6889% | |
| -55.0195% | |
| -29.3326% | |
| -43.9173% | |
| -21.3719% | |
| -27.2207% | |
| -78.2507% | |
| -80.8254% | |
| -89.1439% | |
| -133.904% | |
| -79.7006% | |
| -235.2346% | |
| -237.2024% | |
| -246.1111% | |
| -112.5728% |